Friday, December 8, 2023
WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.
Professor of Vascular Medicine
Amsterdam University Medical Centers
University of Amsterdam
Amsterdam, the Netherlands
Professor of Medicine
Harvard Medical School
Director
Center for Lipid Metabolomics
Brigham and Women’s Hospital
Boston, Massachusetts, United States
Professor
University of Copenhagen
Chief Physician
Department of Clinical Biochemistry
Herlev and Gentofte Hospital
Copenhagen University Hospital
Herlev, Denmark
processing....
Posted: 28/11/2022
This educational activity is intended for an international audience of non-US cardiologists, primary care physicians, and nephrologists.
Upon completion of this activity, participants will:
The goal of this activity is for learners to be better able to apply recent updates on Lp(a) in atherosclerotic cardiovascular disease (ASCVD) and particularly on the 2022 European Atherosclerotic Society (EAS) Consensus Statement.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
